Bank of New York Mellon Corp
BankPosition in AVXL — Anavex Life Sciences Corp.
CIK 1390777
NEW YORK, NY
Position in AVXL
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$746,434
-$14,460 QoQ
Shares Held
288,199
+16.3% QoQ
Ownership
0.311%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 179 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. AVXL ranks #215 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in AVXL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $746,434 | 288,199 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $760,894 | 247,849 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $868,834 | 244,055 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $2,207,322 | 248,014 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $2,134,391 | 231,496 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $1,914,462 | 223,131 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $2,365,472 | 220,249 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,277,885 | 224,980 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,183,944 | 280,556 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,219,873 | 239,661 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $2,384,271 | 256,098 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $1,687,932 | 257,700 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $2,087,043 | 256,709 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $2,181,261 | 254,523 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $2,300,868 | 248,474 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,558,295 | 247,897 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,183,439 | 218,126 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,791,192 | 226,742 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $3,913,828 | 225,711 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $3,903,692 | 217,476 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $5,970,275 | 261,167 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $3,062,101 | 204,823 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,047,874 | 194,051 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $745,234 | 163,788 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $803,089 | 163,230 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $504,194 | 160,062 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||